Avid Bioservices Inc (CDMO)

[honestabe13]

good news for patientsm horrible news for pphm stockholders:
NEW YORK, Nov 18 (Reuters) - U.S. biotechnology company Genentech Inc (DNA.N: Quote, Profile , Research) said on Sunday its blockbuster cancer drug, Avastin, showed encouraging results for patients with the most aggressive form of brain cancer.

In a Phase II trial, the drug, administered alone or with chemotherapy, demonstrated an encouraging six-month survival rate for patients with glioblastoma multiforme (GBM), the most common and aggressive type of brain cancer.

Genentech said 36 percent of patients treated with Avastin alone and 51 percent treated with a combination of the drug and chemotherapy lived without the disease advancing within six months.

as always, pphm too little too late. bye bye cotara